allogeneic transplant in high-risk mm groups
Published 4 years ago • 20 plays • Length 1:03Download video MP4
Download video MP3
Similar videos
-
4:13
when is allogeneic transplant the right answer for mm?
-
3:12
allogeneic hsct in patients with high-risk myeloma
-
1:28
the role of allogeneic transplantation in patients with aml in the frontline setting
-
8:29
allogeneic transplant in multiple myeloma: who should receive it and the future of transplant
-
1:33
the role of allogeneic transplantation in patients with multiple myeloma
-
6:16
allogeneic stem cell transplant: kat's story
-
3:32
potential applications of artificial intelligence in myeloma
-
5:54
redirectt-1 results: teclistamab talquetamab in r/r multiple myeloma
-
4:16
post-allogeneic transplant interventions in all
-
5:46
the use of allogeneic transplantation in the era of checkpoint blockade therapy in hodgkin lymphoma
-
1:56
current investigations in the use of allogeneic transplant in the treatment of myeloma
-
1:55
mm: when is allogeneic transplant is the right answer?
-
3:29
what are the challenges of allogeneic stem cell transplant in myeloma?
-
1:35
the role of allogeneic transplantation in myelofibrosis & patient eligibility for allosct
-
5:18
upfront treatment in transplant candidates
-
1:57
the benefit of allogeneic transplantation in patients with tp53-mutated aml
-
4:01
allogeneic transplant is not the quintessential treatment for all anymore!
-
3:23
the role of allo-transplant for patients with all
-
1:53
transplantation for consolidation in multiple myeloma
-
1:56
the feasibility of chemotherapy-free regimens without allogeneic transplantation in mrd- ph all
-
3:51
bmt ctn 1302: maintenance ixazomib following allohct in patients with high-risk myeloma